biote Corp. (BTMD)
NASDAQ: BTMD · IEX Real-Time Price · USD
7.65
+0.25 (3.38%)
At close: Jul 2, 2024, 4:00 PM
7.47
-0.18 (-2.35%)
After-hours: Jul 2, 2024, 6:55 PM EDT
biote Revenue
biote had revenue of $187.32M in the twelve months ending March 31, 2024, with 8.49% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $46.80M with 4.37% year-over-year growth. In the year 2023, biote had annual revenue of $185.36M with 12.37% growth.
Revenue (ttm)
$187.32M
Revenue Growth
+8.49%
P/S Ratio
2.53
Revenue / Employee
$965,572
Employees
194
Market Cap
474.58M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 185.36M | 20.40M | 12.37% |
Dec 31, 2022 | 164.96M | 25.56M | 18.34% |
Dec 31, 2021 | 139.40M | 22.83M | 19.58% |
Dec 31, 2020 | 116.57M | 6.59M | 5.99% |
Dec 31, 2019 | 109.98M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Community Health Systems | 12.52B |
Cross Country Healthcare | 1.78B |
Enhabit | 1.04B |
Canopy Growth | 218.49M |
Altimmune | 410.00K |
Allogene Therapeutics | 65.00K |
BTMD News
- 12 days ago - Biote Announces $60 Million Agreement to Repurchase 8.3 Million Shares and Cancel Approximately 4.0 Million Earnout Shares - Business Wire
- 2 months ago - Biote Reports First Quarter 2024 Financial Results - Business Wire
- 2 months ago - Biote Announces Definitive Settlement with Founder - Business Wire
- 2 months ago - Biote Schedules First Quarter 2024 Financial Results Release and Conference Call - Business Wire
- 3 months ago - This overlooked corner of women's health could be a $350 billion market opportunity - CNBC
- 4 months ago - Biote Reports Fourth Quarter and Full Year 2023 Financial Results - Business Wire
- 4 months ago - Biote Schedules Fourth Quarter and Full Year 2023 Financial Results Release and Conference Call - Business Wire
- 4 months ago - Biote Announces Agreement to Resolve Litigation and Repurchase All of Founder's Shares - Business Wire